Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 13 Issue: 2
Author(s): Gustav Akk
Affiliation:
Export Options
About this article
Cite this article as:
Akk Gustav, Meet Our Editorial Board Member, Current Neuropharmacology 2015; 13 (2) . https://dx.doi.org/10.2174/1570159X1302150525143440
DOI https://dx.doi.org/10.2174/1570159X1302150525143440 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Stimulant-Related Psychosis in ADHD Treatment: An Update for Past 10 Years
Current Psychopharmacology Engineering Antibodies for Therapy
Current Pharmaceutical Biotechnology Protein Conformational Diseases: From Mechanisms to Drug Designs
Current Drug Discovery Technologies L-Carnitine - Metabolic Functions and Meaning in Humans Life
Current Drug Metabolism Improving the Utility of Steroidal Anti-Inflammatories: Identification of Selective Glucocorticoid Receptor Modulators
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Application of Molecular Imaging Technologies in Antitumor Drug Development and Therapy
Current Pharmaceutical Design TRPM Channels Phosphorylation as a Potential Bridge Between Old Signals and Novel Regulatory Mechanisms of Insulin Secretion
Current Diabetes Reviews Molecular Chaperone Activity and Biological Regulatory Actions of the TPR-Domain Immunophilins FKBP51 and FKBP52
Current Protein & Peptide Science Anti-Cancer Effect of Melatonin via Downregulation of Delta-like Ligand 4 in Estrogen-Responsive Breast Cancer Cells
Recent Patents on Anti-Cancer Drug Discovery Meet Our Editorial Board Member
Current Alzheimer Research Upregulation of Connexin-43 is Critical for Irradiation-induced Neuroinflammation
CNS & Neurological Disorders - Drug Targets Oxidative Stress, Mitochondrial Dysfunction, and Stress Signaling in Alzheimers Disease
Current Alzheimer Research The Interleukin-1 System: An Attractive and Viable Therapeutic Target in Neurodegenerative Disease
Current Drug Targets - CNS & Neurological Disorders Effect of Red Wine Polyphenols on the Expression of Transthyretin in Murine Choroid Plexus
Current Pharmaceutical Biotechnology Neuroimaging of Serotonin System in Anxiety Disorders
Current Pharmaceutical Design Targeting to 5-HT1F Receptor Subtype for Migraine Treatment: Lessons from the Past, Implications for the Future
Central Nervous System Agents in Medicinal Chemistry Medications Acting on the Dopaminergic System in the Treatment of Alcoholic Patients
Current Pharmaceutical Design Nanoporous Silica of Some Egyptian Diatom Frustules as a Promising Natural Material
Nanoscience & Nanotechnology-Asia MYC-mediated Synthetic Lethality for Treatment of Hematological Malignancies
Current Cancer Drug Targets Reconsideration of Japanese Traditional Herbal Medicine: New Field of Research and Clinical Medicine
Mini-Reviews in Medicinal Chemistry